Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment

Immune checkpoint inhibitors (ICIs) such as pembrolizumab have revolutionized the treatment of advanced melanoma, but many patients do not respond to ICIs alone, and thus there is need for additional treatment options. Topical immunomodulators such as diphencyprone (DPCP) also have clinical use in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Joseph, Agarwal, Aneesh, Young, Jade N., Owji, Shayan, Luu, Yen, Poplausky, Dina, Yassky, Daniel, Estrada, Yeriel, Ungar, Jonathan, Krueger, James G., Gulati, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792448/
https://www.ncbi.nlm.nih.gov/pubmed/36572780
http://dx.doi.org/10.1038/s41598-022-27020-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792448/
https://www.ncbi.nlm.nih.gov/pubmed/36572780
http://dx.doi.org/10.1038/s41598-022-27020-1

Ejemplares similares